VKA Monotherapy Linked to Reduced MI, Stroke Risk in A-Fib

Share this content:
VKA Monotherapy Linked to Reduced MI, Stroke Risk in A-Fib
VKA Monotherapy Linked to Reduced MI, Stroke Risk in A-Fib

MONDAY, June 19, 2017 (HealthDay News) -- For patients with atrial fibrillation (AF), vitamin K antagonist (VKA) monotherapy is associated with reduced risk of first-time myocardial infarction (MI) and stroke compared with acetylsalicylic acid (ASA) monotherapy, according to a study published in the June 20 issue of the Journal of the American College of Cardiology.

Christina J.-Y. Lee, M.D., from Aalborg University in Denmark, and colleagues identified subjects with first-time AF diagnosed from 1997 to 2012 without history of coronary artery disease. The authors examined the incidence of first-time MI according to antithrombotic treatment. Data were included for 71,959 patients: 52 percent treated with VKA monotherapy, 35 percent with ASA monotherapy, and 13 percent with dual therapy (VKA + ASA).

The incidence of MI was 3 percent overall. The researchers found that the associated risk of MI was increased for ASA and dual therapy relative to the VKA-treated group (incidence rate ratios [IRR], 1.54 and 1.22, respectively). Dual therapy was associated with a significantly higher bleeding risk (IRR, 1.93). Relative to that of VKA therapy, the risk of stroke was significantly increased for ASA and dual therapy (IRR, 2.00 and 1.30, respectively).

"VKA monotherapy in patients with AF was associated with a lower risk of first-time MI and stroke than ASA monotherapy," the authors write. "Combination of ASA and VKA therapy was not associated with a lower risk of MI but was associated with increased bleeding risk."

Several authors disclosed financial ties to pharmaceutical companies, including Bristol-Myers Squibb and Pfizer, both of which funded the study.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

NTproBNP Levels Are Significantly Lower in Blacks

NTproBNP Levels Are Significantly Lower in Blacks

Higher NTproBNP levels linked to increased risk of death; this association did not differ by race

Data May Weigh on Pros/Cons of Expanded Care Optometry

Data May Weigh on Pros/Cons of Expanded Care ...

Majority of residents in Kentucky, Oklahoma, New Mexico live within 30 minutes of ophthalmologist

Gaps Seen Between Hearing Loss, Receipt of Medical Evaluation, Tx

Gaps Seen Between Hearing Loss, Receipt of Medical ...

About 20.6 percent of those with hearing less than excellent/good had visited doctor for hearing issues

is free, fast, and customized just for you!

Already a member?

Sign In Now »